Market Research Logo

North America Peptide Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

1 Market Overview
1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Oral
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Metabolic Disorders
1.3.3 Central Nervous System
1.3.4 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Mexico Status and Prospect (2013-2023)
1.4.3 Canada Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Peptide Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Peptide Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk
2.3.1 Business Overview
2.3.2 Peptide Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Peptide Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Peptide Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Peptide Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Peptide Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shire
2.8.1 Business Overview
2.8.2 Peptide Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Peptide Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ipsen
2.10.1 Business Overview
2.10.2 Peptide Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Allergan
2.11.1 Business Overview
2.11.2 Peptide Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring
2.12.1 Business Overview
2.12.2 Peptide Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Peptide Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 The Medicines
2.14.1 Business Overview
2.14.2 Peptide Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Peptide Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 J & J
2.16.1 Business Overview
2.16.2 Peptide Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America Peptide Therapeutics Market Competition, by Manufacturer
3.1 North America Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.1.1 North America Peptide Therapeutics Sales by Manufacturer (2016-2017)
3.1.2 North America Peptide Therapeutics Sales Market Share by Manufacturer (2016-2017)
3.2 North America Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America Peptide Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America Peptide Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America Peptide Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Peptide Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America Peptide Therapeutics Market Analysis by Countries
4.1 North America Peptide Therapeutics Sales and Market Share by Countries (2013-2018)
4.1.1 North America Peptide Therapeutics Sales by Countries (2013-2018)
4.1.2 North America Peptide Therapeutics Sales Market Share by Countries (2013-2018)
4.2 North America Peptide Therapeutics Revenue (Value) and Market Share by Countries (2013-2018)
4.2.1 North America Peptide Therapeutics Revenue by Countries (2013-2018)
4.2.2 North America Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
5 North America Market Segmentation Peptide Therapeutics by Type
5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America Peptide Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price
5.2 Injection Sales Growth and Price
5.2.1 North America Injection Sales Growth (2013-2018)
5.2.2 North America Injection Price (2013-2018)
5.3 Oral Sales Growth and Price
5.3.1 North America Oral Sales Growth (2013-2018)
5.3.2 North America Oral Price (2013-2018)
5.4 Other Sales Growth and Price
5.4.1 North America Other Sales Growth (2013-2018)
6 North America Market Segmentation Peptide Therapeutics by Application
6.1 North America Peptide Therapeutics Sales Market Share by Application (2013-2018)
6.2 Cancer Sales Growth (2013-2018)
6.3 Metabolic Disorders Sales Growth (2013-2018)
6.4 Central Nervous System Sales Growth (2013-2018)
6.5 Other Sales Growth (2013-2018)
7 United States Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Peptide Therapeutics Sales and Market Share by Type
7.2.1 United States Peptide Therapeutics Sales by Type (2013-2018)
7.2.2 United States Peptide Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Peptide Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Peptide Therapeutics Sales by Application (2013-2018)
7.3.2 United States Peptide Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Peptide Therapeutics Export and Import (2013-2018)
8 Canada Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 Canada Peptide Therapeutics Sales and Market Share by Type (2013-2018)
8.2.1 Canada Peptide Therapeutics Sales by Type (2013-2018)
8.2.2 Canada Peptide Therapeutics Sales Market Share by Type (2013-2018)
8.3 Canada Peptide Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 Canada Peptide Therapeutics Sales by Application (2013-2018)
8.3.2 Canada Peptide Therapeutics Sales Market Share by Application (2013-2018)
8.4 Canada Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 Canada Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 Canada Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 Canada Peptide Therapeutics Export and Import (2013-2018)
9 Mexico Peptide Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Peptide Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Mexico Peptide Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Mexico Peptide Therapeutics Sales by Type (2013-2018)
9.2.2 Mexico Peptide Therapeutics Sales Market Share by Type (2013-2018)
9.3 Mexico Peptide Therapeutics Sales and Market Share by Application (2013-2018)
9.3.1 Mexico Peptide Therapeutics Sales by Application (2013-2018)
9.3.2 Mexico Peptide Therapeutics Sales Market Share by Application (2013-2018)
9.4 Mexico Peptide Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Mexico Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Mexico Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Mexico Peptide Therapeutics Export and Import (2013-2018)
10 Peptide Therapeutics Market Forecast (2018-2023)
10.1 North America Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
10.2 Peptide Therapeutics Market Forecast by Countries (2018-2023)
10.2.1 North America Peptide Therapeutics Sales Forecast by Countries (2018-2023)
10.2.2 United States Peptide Therapeutics Forecast (2018-2023)
10.2.3 Canada Peptide Therapeutics Forecast (2018-2023)
10.2.4 Mexico Peptide Therapeutics Forecast (2018-2023)
10.3 Peptide Therapeutics Market Forecast by Type (2018-2023)
10.3.1 North America Peptide Therapeutics Sales Forecast by Type (2018-2023)
10.3.2 North America Peptide Therapeutics Market Share Forecast by Type (2018-2023)
10.4 Peptide Therapeutics Market Forecast by Application (2018-2023)
10.4.1 North America Peptide Therapeutics Sales Forecast by Application (2018-2023)
10.4.2 North America Peptide Therapeutics Market Share Forecast by Application (2018-2023)
11 Peptide Therapeutics Manufacturing Cost Analysis
11.1 Peptide Therapeutics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Peptide Therapeutics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Peptide Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2017
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Peptide Therapeutics Picture
Table Product Specifications of Peptide Therapeutics
Figure North America Sales Market Share of Peptide Therapeutics by Types in 2017
Table Types of Peptide Therapeutics
Figure Injection Picture
Figure Oral Picture
Figure Other Picture
Figure North America Peptide Therapeutics Sales Market Share by Applications in 2017
Table Applications of Peptide Therapeutics
Figure Cancer Picture
Figure Metabolic Disorders Picture
Figure Central Nervous System Picture
Figure Other Picture
Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Mexico Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Peptide Therapeutics Type and Applications
Table Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Peptide Therapeutics Type and Applications
Table Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Peptide Therapeutics Type and Applications
Table Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Peptide Therapeutics Type and Applications
Table Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Peptide Therapeutics Type and Applications
Table Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Peptide Therapeutics Type and Applications
Table AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Peptide Therapeutics Type and Applications
Table Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Peptide Therapeutics Type and Applications
Table Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Peptide Therapeutics Type and Applications
Table AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Peptide Therapeutics Type and Applications
Table Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Peptide Therapeutics Type and Applications
Table Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ferring Basic Information, Manufacturing Base and Competitors
Table Ferring Peptide Therapeutics Type and Applications
Table Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Peptide Therapeutics Type and Applications
Table Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table The Medicines Basic Information, Manufacturing Base and Competitors
Table The Medicines Peptide Therapeutics Type and Applications
Table The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Peptide Therapeutics Type and Applications
Table Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table J & J Basic Information, Manufacturing Base and Competitors
Table J & J Peptide Therapeutics Type and Applications
Table J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Peptide Therapeutics Sales by Manufacturer (2016-2017)
Table North America Peptide Therapeutics Sales Market Share by Manufacturer (2016-2017)
Figure North America Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table North America Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Table North America Peptide Therapeutics Revenue Market Share by Manufacturer (2016-2017)
Figure North America Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America Peptide Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Peptide Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Peptide Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Peptide Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Peptide Therapeutics Manufacturer Market Share in 2017
Table North America Peptide Therapeutics Sales by Countries (2013-2018)
Figure North America Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table North America Peptide Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America 2013 Peptide Therapeutics Sales Market Share by Countries
Figure North America 2017 Peptide Therapeutics Sales Market Share by Countries
Table North America Peptide Therapeutics Revenue by Countries (2013-2018)
Figure North America Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Peptide Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America 2013 Peptide Therapeutics Revenue Market Share by Countries
Figure North America 2017 Peptide Therapeutics Revenue Market Share by Countries
Table North America Peptide Therapeutics Sales by Type (2013-2018)
Table North America Peptide Therapeutics Sales Share by Type (2013-2018)
Table North America Peptide Therapeutics Revenue by Type (2013-2018)
Table North America Peptide Therapeutics Revenue Share by Type (2013-2018)
Figure North America Injection Sales Growth (2013-2018)
Figure North America Injection Price (2013-2018)
Figure North America Oral Sales Growth (2013-2018)
Figure North America Oral Price (2013-2018)
Figure North America Other Sales Growth (2013-2018)
Figure North America Other Price (2013-2018)
Table North America Peptide Therapeutics Sales by Application (2013-2018)
Table North America Peptide Therapeutics Sales Share by Application (2013-2018)
Figure North America Cancer Sales Growth (2013-2018)
Figure North America Metabolic Disorders Sales Growth (2013-2018)
Figure North America Central Nervous System Sales Growth (2013-2018)
Figure North America Other Sales Growth (2013-2018)
Figure United States Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table United States Peptide Therapeutics Sales by Type (2013-2018)
Table United States Peptide Therapeutics Sales Market Share by Type (2013-2018)
Table United States Peptide Therapeutics Sales by Application (2013-2018)
Table United States Peptide Therapeutics Sales Market Share by Application (2013-2018)
Table United States Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United States Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table United States Peptide Therapeutics Export and Import (2013-2018)
Figure Canada Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table Canada Peptide Therapeutics Sales by Type (2013-2018)
Table Canada Peptide Therapeutics Sales Market Share by Type (2013-2018)
Table Canada Peptide Therapeutics Sales by Application (2013-2018)
Table Canada Peptide Therapeutics Sales Market Share by Application (2013-2018)
Table Canada Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Canada Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Canada Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Canada Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Canada Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Canada Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Canada Peptide Therapeutics Export and Import (2013-2018)
Figure Mexico Peptide Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Peptide Therapeutics Sales and Growth Rate (2013-2018)
Table Mexico Peptide Therapeutics Sales by Type (2013-2018)
Table Mexico Peptide Therapeutics Sales Market Share by Type (2013-2018)
Table Mexico Peptide Therapeutics Sales by Application (2013-2018)
Table Mexico Peptide Therapeutics Sales Market Share by Application (2013-2018)
Table Mexico Peptide Therapeutics Sales by Manufacturer (2016-2017)
Figure Mexico Peptide Therapeutics Sales Market Share by Manufacturer in 2016
Figure Mexico Peptide Therapeutics Sales Market Share by Manufacturer in 2017
Table Mexico Peptide Therapeutics Revenue by Manufacturer (2016-2017)
Figure Mexico Peptide Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Mexico Peptide Therapeutics Revenue Market Share by Manufacturer in 2017
Table Mexico Peptide Therapeutics Export and Import (2013-2018)
Figure North America Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table North America Peptide Therapeutics Sales Forecast by Countries (2018-2023)
Table North America Peptide Therapeutics Market Share Forecast by Countries (2018-2023)
Figure United States Peptide Therapeutics Sales Forecast (2018-2023)
Figure Canada Peptide Therapeutics Sales Forecast (2018-2023)
Figure Mexico Peptide Therapeutics Sales Forecast (2018-2023)
Table North America Peptide Therapeutics Sales Forecast by Type (2018-2023)
Table North America Peptide Therapeutics Market Share Forecast by Type (2018-2023)
Table North America Peptide Therapeutics Sales Forecast by Application (2018-2023)
Table North America Peptide Therapeutics Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2017
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders/ Dealers List

North America Peptide Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

Scope of the Report:
This report focuses on the Peptide Therapeutics in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Countries, covering
Injection
Oral
Other

Market Segment by Type, covers
Cancer
Metabolic Disorders
Central Nervous System
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

There are 15 Chapters to deeply display the North America Peptide Therapeutics market.

Chapter 1, to describe Peptide Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Peptide Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Peptide Therapeutics, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Peptide Therapeutics market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Peptide Therapeutics Research Findings and Conclusion, Appendix, methodology and data source


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;